Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene...

Area of Science:

• Molecular biology
• Gene regulation
• Mammary gland development

Background:

• CCAAT/enhancer-binding protein (C/EBP) is crucial for mammary gland function.
• C/EBP binding sites are present in the rat beta-casein gene promoter.
• C/EBP protein levels fluctuate during mammary gland development.

Purpose of the Study:

• To investigate the role of C/EBP proteins in regulating rat beta-casein gene expression.
• To analyze changes in C/EBP alpha and C/EBP beta isoform expression during mammary gland development.
• To determine the effect of glucocorticoids on C/EBP beta isoforms.

Main Methods:

• Western blot analysis to quantify C/EBP protein levels.
• Analysis of C/EBP binding site interactions in the beta-casein gene promoter.
• Treatment of HC11 mammary epithelial cells with hydrocortisone.

Main Results:

• C/EBP alpha expression is high during lactation and low during pregnancy.
• C/EBP beta isoforms (LAP and LIP) show dynamic changes, with a low LAP/LIP ratio during pregnancy and a high ratio during lactation.
• Hydrocortisone treatment inhibits LIP expression, suggesting a role for glucocorticoids in regulating the LAP/LIP ratio.

Conclusions:

• C/EBP proteins play a significant role in the developmental regulation of beta-casein gene expression.
• The ratio of C/EBP beta activating (LAP) to inhibitory (LIP) isoforms is a key determinant of beta-casein gene expression.
• Glucocorticoids may influence beta-casein gene expression by modulating the LAP/LIP ratio.